World Health Organization. World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance (WHO, 2025).
Leong, Y. W., Russell, B., Malleret, B. & Renia, L. Erythrocyte tropism of malarial parasites: the reticulocyte appeal. Front. Microbiol. 13, 1022828 (2022).
Junqueira, C. et al. Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes. Nat. Med. 24, 1330–1336 (2018).
Kurtovic, L. et al. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure. BMC Med. 17, 45 (2019).
Duffy, P. E. Current approaches to malaria vaccines. Curr. Opin. Microbiol. 70, 102227 (2022).
Richie, T. L. et al. Sporozoite immunization: innovative translational science to support the fight against malaria. Expert Rev. Vaccines 22, 964–1007 (2023).
Moorthy, V., Hamel, M. J. & Smith, P. G. Malaria vaccines for children: and now there are two. Lancet 403, 504–505 (2024).
White, M. T. et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect. Dis. 15, 1450–1458 (2015).
Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet 403, 533–544 (2024).
da Veiga, G. T. S., Moriggi, M. R., Vettorazzi, J. F., Muller-Santos, M. & Albrecht, L. Plasmodium vivax vaccine: what is the best way to go? Front. Immunol. 13, 910236 (2022).
Purcell, A. W., Ramarathinam, S. H. & Ternette, N. Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics. Nat. Protoc. 14, 1687–1707 (2019).
Trolle, T. et al. The length distribution of class I-restricted T cell epitopes is determined by both peptide supply and MHC allele-specific binding preference. J. Immunol. 196, 1480–1487 (2016).
Kim, A. et al. Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms. Sci. Rep. 7, 7761 (2017).
Sa, J. M., Cannon, M. V., Caleon, R. L., Wellems, T. E. & Serre, D. Single-cell transcription analysis of Plasmodium vivax blood-stage parasites identifies stage- and species-specific profiles of expression. PLoS Biol. 18, e3000711 (2020).
Kim, A., Popovici, J., Menard, D. & Serre, D. Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes. Nat. Commun. 10, 371 (2019).
Mancio-Silva, L. et al. A single-cell liver atlas of Plasmodium vivax infection. Cell Host Microbe 30, 1048–1060 (2022).
Ruberto, A. A. et al. Single-cell RNA sequencing of Plasmodium vivax sporozoites reveals stage- and species-specific transcriptomic signatures. PLoS Negl. Trop. Dis. 16, e0010633 (2022).
The Plasmodium Genome Database Collaborative. PlasmoDB: an integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data. Nucleic Acids Res. 29, 66–69 (2001).
Howick, V. M. et al. The Malaria Cell Atlas: single parasite transcriptomes across the complete Plasmodium life cycle. Science 365, eaaw2619 (2019).
Zanghi, G. et al. Genome-wide gene expression profiles throughout human malaria parasite liver stage development in humanized mice. Nat. Microbiol. 10, 569–584 (2025).
Ferreira, M. U. et al. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys. Lancet Reg. Health Am. 9, 100169 (2022).
Almeida, G. G. et al. Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: submicroscopic parasitemic blood infects Nyssorhynchus darlingi. PLoS Negl. Trop. Dis. 15, e0009077 (2021).
Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360–3368 (2017).
Braud, V., Jones, E. Y. & McMichael, A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27, 1164–1169 (1997).
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. & Brooks, A. G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813–818 (1998).
Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H. & Geraghty, D. E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160, 4951–4960 (1998).
Walters, L. C. et al. Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes. Cell Rep. 39, 110959 (2022).
Walters, L. C. et al. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding. Nat. Commun. 9, 3137 (2018).
Flyer, D. C. et al. Identification by mass spectrometry of CD8+-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product. Infect. Immun. 70, 2926–2932 (2002).
He, W. et al. Intracellular trafficking of HLA-E and its regulation. J. Exp. Med. 220, e20221941 (2023).
Celik, A. A., Kraemer, T., Huyton, T., Blasczyk, R. & Bade-Doding, C. The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch. Immunogenetics 68, 29–41 (2016).
Kaseke, C. et al. HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV. Cell Rep. 36, 109378 (2021).
Salerno-Goncalves, R., Fernandez-Vina, M., Lewinsohn, D. M. & Sztein, M. B. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 173, 5852–5862 (2004).
Walters, L. C., McMichael, A. J. & Gillespie, G. M. Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay. Eur. J. Immunol. 50, 2075–2091 (2020).
Joyner, C. et al. Plasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infections. Malar. J. 15, 451 (2016).
Muh, F. et al. Plasmodium cynomolgi: what should we know? Microorganisms 12, 1607 (2024).
Ruibal, P. et al. Peptide binding to HLA-E molecules in humans, nonhuman primates, and mice reveals unique binding peptides but remarkably conserved anchor residues. J. Immunol. 205, 2861–2872 (2020).
Jackson, K. E. et al. Protein translation in Plasmodium parasites. Trends Parasitol. 27, 467–476 (2011).
Mwakingwe-Omari, A. et al. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. Nature 595, 289–294 (2021).
Abuelazm, M. T. et al. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials. Infection 52, 707–722 (2024).
Mordmuller, B. et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542, 445–449 (2017).
Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475–480 (2011).
de Lacerda, L., Castro, G., Gomes, C. & Junqueira, C. In vitro assay of Plasmodium-infected red blood cell killing by cytotoxic lymphocytes. J. Vis. Exp. 186, e63987 (2022).
Leddy, O. K., White, F. M. & Bryson, B. D. Leveraging immunopeptidomics to study and combat infectious disease. mSystems 6, e0031021 (2021).
Blatnik, R. et al. A targeted LC–MS strategy for low-abundant HLA class-I-presented peptide detection identifies novel human papillomavirus T-cell epitopes. Proteomics 18, e1700390 (2018).
Newey, A. et al. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. J. Immunother. Cancer 7, 309 (2019).
Kennedy, S. C. et al. Identification of mycobacterial ribosomal proteins as targets for CD4+ T cells that enhance protective immunity in tuberculosis. Infect. Immun. 86, e00009-18 (2018).
Mou, Z. et al. Identification of a protective Leishmania antigen dihydrolipoyl dehydrogenase and its responding CD4+ T cells at clonal level. J. Immunol. 205, 1355–1364 (2020).
Bettencourt, P. et al. Identification of antigens presented by MHC for vaccines against tuberculosis. npj Vaccines 5, 2 (2020).
Versteeg, L. et al. Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate. PLoS Pathog. 20, e1012764 (2024).
Arisue, N. et al. The Plasmodium apicoplast genome: conserved structure and close relationship of P. ovale to rodent malaria parasites. Mol Biol Evol 29, 2095–2099 (2012).
Liang, X. et al. Puf3 participates in ribosomal biogenesis in malaria parasites. J. Cell Sci. 131, jcs212597 (2018).
Fabreti-Oliveira, R. A., Nascimento, E., Fonseca, C. G. & Santos, M. A. The heterogeneous HLA genetic composition of the Brazilian population and its relevance to the optimization of hematopoietic stem cell donor recruitment. Tissue Antigens 84, 187–197 (2014).
Frahm, N. et al. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 37, 2419–2433 (2007).
Lopez de Castro, J. A. How ERAP1 and ERAP2 shape the peptidomes of disease-associated MHC-I proteins. Front. Immunol. 9, 2463 (2018).
Ramalho, J., Veiga-Castelli, L. C., Donadi, E. A., Mendes-Junior, C. T. & Castelli, E. C. HLA-E regulatory and coding region variability and haplotypes in a Brazilian population sample. Mol. Immunol. 91, 173–184 (2017).
Valencia-Hernandez, A. M. et al. A natural peptide antigen within the Plasmodium ribosomal protein RPL6 confers liver TRM cell-mediated immunity against malaria in mice. Cell Host Microbe 27, 950–962 (2020).
Longley, R. J. et al. Assessment of the Plasmodium falciparum preerythrocytic antigen UIS3 as a potential candidate for a malaria vaccine. Infect. Immun. 85, e00641-16 (2017).
Collins, K. A. et al. A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions. J. Clin. Invest. 130, 2920–2927 (2020).
Boyum, A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97, 77–89 (1968).
Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543–D553 (2025).
Lopez-Barragan, M. J. et al. Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum. BMC Genomics 12, 587 (2011).
Zanghi, G. et al. A specific PfEMP1 Is expressed in P. falciparum sporozoites and plays a role in hepatocyte infection. Cell Rep. 22, 2951–2963 (2018).
Tarun, A. S. et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl Acad. Sci. USA 105, 305–310 (2008).
Lapp, S. A. et al. Plasmodium knowlesi gene expression differs in ex vivo compared to in vitro blood-stage cultures. Malar. J. 14, 110 (2015).
Caldelari, R. et al. Transcriptome analysis of Plasmodium berghei during exo-erythrocytic development. Malar. J. 18, 330 (2019).
Otto, T. D. et al. A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biol. 12, 86 (2014).
Cubi, R. et al. Laser capture microdissection enables transcriptomic analysis of dividing and quiescent liver stages of Plasmodium relapsing species. Cell. Microbiol. 19, e12735 (2017).
Voorberg-van der Wel, A. et al. A comparative transcriptomic analysis of replicating and dormant liver stages of the relapsing malaria parasite Plasmodium cynomolgi. eLife 6, e29605 (2017).
Soulard, V. et al. Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice. Nat. Commun. 6, 7690 (2015).
Winnicki, A. C. et al. Potent AMA1-specific human monoclonal antibody against Plasmodium vivax pre-erythrocytic and blood stages. Nat. Commun. 15, 10556 (2024).
Teirlinck, A. C. et al. NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections. J Infect. Dis. 207, 656–660 (2013).
Zevin, A. S. et al. Laparoscopic technique for serial collection of liver and mesenteric lymph nodes in macaques. J. Vis. Exp. 123, e55617 (2017).
Hansen, S. G. et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523–527 (2011).
Hansen, S. G. et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328, 102–106 (2010).
Hansen, S. G. et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15, 293–299 (2009).
Hojo-Souza, N. S. et al. Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage. PLoS Pathog. 16, e1008840 (2020).
Pahl-Seibert, M. F. et al. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J. Virol. 79, 5400–5413 (2005).
Rezvani, K. et al. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood 113, 2245–2255 (2009).
Motiee, M., Zavaran Hosseini, A., Soudi, S. & Hassanzadeh, S. M. The effect of antigen dose and antigen presenting process on T cell stimulation: a method for enrichment of TB10.4 antigen-specific T-cell clones. Iran. J. Allergy Asthma Immunol. 20, 364–375 (2021).
Junqueira, C. et al. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PLoS ONE 7, e36245 (2012).
